CorMedix (CRMD) Depreciation & Amortization (CF) (2010 - 2025)
CorMedix (CRMD) reported Depreciation & Amortization (CF) of $294096.0 for Q4 2025, up 259.57% on a YoY basis from $81790.0 in Q4 2024, and up 81.63% sequentially from $161917.0 in Q3 2025.
CorMedix (CRMD) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends
CorMedix (CRMD) has 15 years of Depreciation & Amortization (CF) data on file, last reported at $294096.0 in Q4 2025.
- For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 259.57% year-over-year to $294096.0; the trailing twelve-month figure through Dec 2025 stood at $677000.0 (up 339.61% YoY), and the FY2025 full-year result was $677000.0, up 339.61% from the prior year.
- Depreciation & Amortization (CF) advanced to $294096.0 in Q4 2025, from $161917.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $294096.0 in Q4 2025 to a low of $11994.0 in Q1 2021.
- A 5-year average of $52413.2 and a median of $20925.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) tumbled 75.15% in 2021 and jumped 535.97% in 2025, its largest moves.
- Tracing CRMD's Depreciation & Amortization (CF) over 5 years: stood at $20047.0 in 2021, then rose by 12.32% to $22516.0 in 2022, then retreated by 17.08% to $18670.0 in 2023, then surged by 338.08% to $81790.0 in 2024, then jumped by 259.57% to $294096.0 in 2025.
- Business Quant data shows CRMD's Depreciation & Amortization (CF) at $294096.0 in Q4 2025, $161917.0 in Q3 2025, and $110993.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | 294,096.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 294,096.00 |
| Dec 31, 2025 | 294,096.00 |
| Sep 30, 2025 | 161,917.00 |
| Sep 30, 2025 | 161,917.00 |
| Jun 30, 2025 | 110,993.00 |
| Jun 30, 2025 | 110,993.00 |
| Mar 31, 2025 | 109,994.00 |
| Mar 31, 2025 | 109,994.00 |
| Dec 31, 2024 | 81,790.00 |
| Dec 31, 2024 | 81,790.00 |
| Sep 30, 2024 | 25,460.00 |
| Sep 30, 2024 | 25,460.00 |
| Jun 30, 2024 | 24,924.00 |
| Jun 30, 2024 | 24,924.00 |
| Mar 31, 2024 | 21,826.00 |
| Mar 31, 2024 | 21,826.00 |
| Dec 31, 2023 | 18,670.00 |
| Dec 31, 2023 | 18,670.00 |
| Sep 30, 2023 | 17,793.00 |
| Sep 30, 2023 | 17,793.00 |